www.jimtrade.com
Menu

Medium-To-Long Acting Oral Anti-Diabetic Drug

Image Not Available

Product Category :    Pharmaceuticals

Supplier                :    Sri Pharmacare

Inquire Now
Product Profile of Medium-to-Long Acting Oral Anti-diabetic Drug

Medium-to-Long Acting Oral Anti-diabetic Drug is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Medium-to-Long Acting Oral Anti-diabetic Drug is manufactured by Sri Pharmacare which is WHO-GMP certified. Sri Pharmacare also manufactures various types of pharmaceutical formulations in the form of tablets, capsules, soft gelatine capsules, injections, eye drops, syrups and liquids etc. The Medium-to-Long Acting Oral Anti-diabetic Drug has 5 mg glipizide. This Anti-diabetic Drug blocks the potassium channels in the beta cells of the islets of langerhans. By partially blocking the potassium channels, it increases the time the cell spends in the calcium release stage of cell signalling leading to an increase in calcium which in turn initiates more insulin release from each beta cell.

Recently Updated Products



Automatic Hand Sanitizer Dispenser
Automatic Hand Sanitizer Dispenser
Supplier    :    Crossways Vertical Solutions Private Limited
Inquire Now
Ciprofloxacin Eye/Ear Drops BP 0.3%
Ciprofloxacin Eye/Ear Drops BP 0.3%
Supplier    :    Prowill Pharma
Inquire Now
Eyedrop for Pharmaceutical Industry
Eyedrop for Pharmaceutical Industry
Supplier    :    Syntho Pharmaceuticals Pvt Ltd
Inquire Now
Antiseptic Liquid For Pharmaceutical Industry
Antiseptic Liquid For Pharmaceutical Industry
Supplier    :    Novopharm Formulations Private Limited
Inquire Now
Pharmaceutical Grade Nasal Spray
Pharmaceutical Grade Nasal Spray
Supplier    :    Novopharm Formulations Private Limited
Inquire Now